![\"image](\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/05\/1779548611_718_screenshot_6_5_2026_15363_www_koreabiomed_com-27599.jpeg\")
<\/p>\n\t\t\t\t\t\tBasel Area Business & Innovation inks new collaboration with Korean biopharma companies<\/p>\n
May 6, 2026 | Wednesday | News<\/p>\n
\t\t\t\t\t\t\tAgreement aims to be a flagship programme that bridges Korea and the global market<\/p>\n
\t\t\t\t\t\t\t\t<\/p>\n
image credit- Roche Korea<\/p>\n
Basel Area Business & Innovation, the strategic growth partner helping ventures in science and tech to land, launch and level up inside Europe’s transformative life sciences supercluster, has announced a new collaboration with leading Korean biopharmas.<\/p>\n
The partnership with Roche Korea, the Korea Health Industry Development Institute (KHIDI), and the Korea Technology Finance Corporation (KIBO) will help high-potential biopharma companies expand into global markets, including the United States.<\/p>\n
This collaboration demonstrates a new model for international ecosystem building, one that combines market access, industry expertise, and increased collaboration. At its core, the partnership is about creating a clearer, faster path for Korean biotech and pharmaceutical companies to access global expertise, capital, and infrastructure, while also building stronger connections with key innovation markets across the globe.<\/p>\n
The partners will launch a joint open innovation program beginning in May 2026, starting with selected participating companies. Each organization brings a distinct role:<\/p>\n
\n
<\/p>\n
Roche Korea\u00a0will lead company selection and explore opportunities for funding, mentoring, and collaboration.<\/p>\n
\n
\n
<\/p>\n
KHIDI\u00a0will promote and help operate the program, identifying strong candidates.<\/p>\n
\n
\n
<\/p>\n
KIBO\u00a0will evaluate companies and support access to financing to help accelerate growth.<\/p>\n
\n
\n
<\/p>\n
Basel Area Business & Innovation\u00a0will connect companies to the Basel Area Life Sciences Supercluster and provide access to infrastructure, including the\u00a0Switzerland Innovation Park Basel Area.<\/p>\n
\n
<\/p>\n
\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Basel Area Business & Innovation inks new collaboration with Korean biopharma companies May 6, 2026 | Wednesday |…\n","protected":false},"author":2,"featured_media":70931,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[1115,2974,8960,2536,134],"class_list":["post-70930","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-biotech","tag-global","tag-korea","tag-pharma","tag-roche"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116624504054954794","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/70930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=70930"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/70930\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/70931"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=70930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=70930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=70930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}